Cargando…
Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy
INTRODUCTION: With the rising prevalence of type 2 diabetes in Australia, screening and earlier diagnosis is needed to provide opportunities to intervene with evidence-based lifestyle and treatment options to reduce the individual, social and economic impact of the disease. The objectives of the Pha...
Autores principales: | Krass, Ines, Carter, Rob, Mitchell, Bernadette, Mohebbi, Mohammadreza, Shih, Sophy T F, Trinder, Peta, Versace, Vincent L, Wilson, Frances, Namara, Kevin Mc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770957/ https://www.ncbi.nlm.nih.gov/pubmed/29284715 http://dx.doi.org/10.1136/bmjopen-2017-017725 |
Ejemplares similares
-
Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial
por: Krass, Ines, et al.
Publicado: (2023) -
A Comparison of Screening Methods for Sleep Disorders in Australian Community Pharmacies: A Randomized Controlled Trial
por: Fuller, Joanne M., et al.
Publicado: (2014) -
Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study
por: Alzubaidi, Hamzah Tareq, et al.
Publicado: (2019) -
Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2023) -
Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies
por: Varas-Doval, R., et al.
Publicado: (2021)